Immunologic therapeutic approaches in the management of food allergy

Expert Review of Clinical Immunology

Volumn 5, Issue 3, 2009, Pages 301-310

  Wang, Julie ^a   Sicherer, Scott H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Anaphylaxis; Food allergen; Food allergy; Food hypersensitivity; Treatment

Indexed keywords

ALLERGEN; CYTOKINE; CYTOKINE ANTIBODY; HERBACEOUS AGENT; IMMUNOGLOBULIN E ANTIBODY; PLASMID DNA; RECOMBINANT VACCINE; TOLL LIKE RECEPTOR 9;

ANAPHYLAXIS; CELLULAR IMMUNITY; CHINESE HERB; CLINICAL TRIAL; FOOD ALLERGY; HUMAN; HUMORAL IMMUNITY; IMMUNOTHERAPY; OUTPATIENT; PATIENT EDUCATION; REMISSION; REVIEW;

EID: 77649092389     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.09.12     Document Type: Review

References (73)

1. Sicherer SH, Sampson HA. Food allergy. J. Allergy Clin. Immunol. 117(2 Suppl.), S470-S475 (2006
2. Decker WW, Campbell RL, Manivannan V et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J. Allergy Clin. Immunol. 122, 1161-1165 (2008
3. Skripak JM, Matsui EC, Mudd K, Wood RA. The natural history of IgE-mediated cow's milk allergy. J. Allergy Clin. Immunol. 120, 1172-1177 (2007
4. Savage JH, Matsui EC, Skripak JM, Wood RA. The natural history of egg allergy. J. Allergy Clin. Immunol. 120, 1413-1417 (2007
5. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J. Allergy Clin. Immunol. 107, 191-193 (2001
6. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food 2001-2006. J. Allergy Clin. Immunol. 119, 1016-1018 (2007
7. Pumphrey RSH, Gowland MH. Further fatal allergic reactions to foods in the United Kingdom, 1999-2006. J. Allergy Clin. Immunol. 119, 1018-1019 (2007
8. Yu JW, Kagan R, Verreault N et al. Accidental ingestions in children with peanut allergy. J. Allergy Clin. Immunol. 118, 466-472 (2006
9. Cohen BL, Noone S, Munoz-Furlong A, Sicherer SH. Development of a questionnaire to measure quality of life in families with a child with food allergy. J. Allergy Clin. Immunol. 114, 1159-1163 (2004
10. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N. Engl. J. Med. 327(6), 380-384 (1992
11. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J. Allergy Clin. Immunol. 119, 780-791 (2007
12. Joint Task Force on Practice Parameters. American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Ann. Allergy Asthma Immunol. 90, 1-40 (2003
13. Saltoun C, Avila PC. Advances in upper airway diseases and allergen immunotherapy in 2007. J. Allergy Clin. Immunol. 122(3), 481-487 (2008
14. Freeman J. 'Rush' inoculation. Lancet 1, 744 (1930
15. Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DYM. Treatment of peanut allergy with rush immunotherapy. J. Allergy Clin. Immunol. 90, 256-262 (1992
16. Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J. Allergy Clin. Immunol. 99(6 Pt 1), 744-751 (1997
17. Bullock RJ, Barnett D, Howden ME. Immunologic and clinical responses to parenteral immunotherapy in peanut anaphylaxis - a study using IgE and IgG4 immunoblot monitoring. Allergol. Immunopathol. (Madr.) 33(5), 250-256 (2005
18. Bohle B. The impact of pollen-related food allergens on pollen allergy. Allergy 62, 3-10 (2007
19. Alonso R, Enrique E, Pineda F et al. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy. Int. Arch. Allergy Immunol. 143, 185-189 (2007
20. Czarnecka-Operacz M, Jenerowicz D, Silny W. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy. Acta Dermatovenerol. Croat. 16, 19-24 (2008
21. Patriarca G, Nucera E, Pollastrini E et al. Oral specific desensitization in food-allergic children. Dig. Dis. Sci. 52(7), 1662-1672 (2007
22. Patriarca G, Nucera E, Roncallo C et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol. Ther. 17(3), 459-465 (2003
23. Meglio P, Bartone E, Plantamura M, Arabito E, Giampietro PG. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 59(9), 980-987 (2004
24. Nucera E, Schiavino D, D'Ambrosio C, Stabile A, Rumi C, Gasbarrini G. Immunological aspects of oral desensitization in food allergy. Dig. Dis. Sci. 45(3), 637-641 (2000
25. Buchanan AD, Green TD, Jones SM et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J. Allergy Clin. Immunol. 119(1), 199-205 (2007
26. Morisset M, Moneret-Vautrin DA, Guenard L et al. Oral desensitization in children with milk and egg allergies obtains recovery in a significant proportion of cases. A randomized study in 60 children with cow's milk allergy and 90 children with egg allergy. Allerg. Immunol. (Paris) 39(1), 12-19 (2007
27. Staden U, Rolnick-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 62(11), 1261-1269 (2007
28. Skripak JM, Nash SD, Rowley H et al. A randomized, double-blind, placebocontrolled study of milk oral immunotherapy for cow's milk allergy. J. Allergy Clin. Immunol. 122, 1154-1160 (2008
29. Longo G, Barbi E, Berti I et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J. Allergy Clin. Immunol. 121(2), 343-347 (2008
30. Staden U, Blumchen K, Blankenstein N et al. Rush oral immunotherapy in children with persistent cow's milk allergy. J. Allergy Clin. Immunol. 122(2), 418-419 (2008
31. Mempel M, Rakoski J, Ring J, Ollert M. Severe anaphylaxis to kiwi fruit: immunologic changes related to successful sublingual allergen immunotherapy. J. Allergy Clin. Immunol. 111(6), 1406-1409 (2003
32. Kerzl R, Simonowa A, Ring J, Ollert M, Mempel M. Life-threatening anaphylaxis to kiwi fruit: protective sublingual allergen immunotherapy effect persists even after discontinuation. J. Allergy Clin. Immunol. 119(2), 507-508 (2007
33. Enrique E, Pineda F, Malek T et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J. Allergy Clin. Immunol. 116(5), 1073-1079 (2005
34. Enrique E, Malek T, Pineda F et al. Sublingual immunotherapy for hazelnut food allergy: a follow-up study. Ann. Allergy Asthma Immunol. 100(3), 283-284 (2008
35. Kinaciyan T, Jahn-Schmid B, Radakovics A et al. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. J. Allergy Clin. Immunol. 119, 937-943 (2007
36. King N, Helm R, Stanley JS et al. Allergenic characteristics of a modified peanut allergen. Mol. Nutr. Food Res. 49(10), 963-971 (2005
37. Bannon GA, Cockrell G, Connaughton C et al. Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy. Int. Arch. Allergy Immunol. 124(1-3), 70-72 (2001
38. Ma Y, Gadermaier G, Bohle B et al. Mutational analysis of amino acid positions crucial for IgE-binding epitopes of the major apple (Maldus domestica) allergen, Mal d 1. Int. Arch. Allergy Immunol. 139(1), 53-62 (2006
39. Swoboda I, Bugajska-Schretter A, Linhart B et al. A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy. J. Immunol. 178(10), 6290-6296 (2007
40. Li XM, Srivastava K and Grishin A et al. Persistent protective effect of heat-killed Escherichia coli producing 'engineered', recombinant peanut proteins in a murine model of peanut allergy. J. Allergy Clin. Immunol. 112(1), 159-167 (2003
41. Bissonnette EY, Befus AD. Inhibition of mast cell-mediated cytotoxicity by IFN-a/b and -g. J. Immunol. 145(10), 3385-3390 (1990
42. Pierkes M, Bellinghausen I, Hultsch T, Metz G, Knop J, Saloga J. Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-g production of T cells. J. Allergy Clin. Immunol. 103(2 Pt 1), 326-332 (1999
43. Niederberger V, Reisinger J, Valent P et al. Vaccination with genetically modified birch pollen allergens: immune and clinical effects on oral allergy syndrome. J. Allergy Clin. Immunol. 119, 1013-1016 (2007
44. Hong SJ, Michael JG, Fehringer A, Leung DY. Pepsin-digested peanut contains T-cell epitopes but no IgE epitopes. J. Allergy Clin. Immunol. 104(2 Pt 1), 473-478 (1999
45. Li S, Li XM, Burks AW, Bannon GA, Sampson HA. Modulation of peanut allergy by peptide-based immunotherapy. J. Allergy Clin. Immunol. 107(2), S233 (2001
46. King N, Helm R, Stanley JS et al. Allergenic characteristics of a modified peanut protein. Mol. Nutr. Food Res. 49, 963-971 (2005
47. Glaspole IN, deLeon MP, Rolland JM, O'Hehir RE. Characterization of the T-cell epitopes of a major peanut allergen, Ara h 2. Allergy 60, 35-40 (2005
48. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186(10), 1623-1631 (1997
49. Tighe H, Takabayashi K and Schwartz D et al. Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J. Allergy Clin. Immunol. 106(1 Pt 1), 124-134 (2000
50. Horner AA, Nguyen MD, Ronaghy A, Cinman N, Verbeek S, Raz E. DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice. J. Allergy Clin. Immunol. 106(2), 349-356 (2000
51. Srivastava K, Li XM, Bannon GA et al. Investigation of the use of ISS-linked Ara h2 for the treatment of peanut-induced allergy. J. Allergy Clin. Immunol. 107(2), S233 (2001
52. Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan: DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5(4), 387-391 (1999
53. Milgrom H. Anti-IgE therapy in allergic disease. Curr. Opin. Pediatr. 16, 642-647 (2004
54. Leung DY, Sampson HA, Yunginger JW et al. Effect of anti-IgE therapy in patients with peanut allergy. N. Engl. J. Med. 348(11), 986-993 (2003
55. Sampson HA, Leung DYM, Burks AW et al. A Phase II, randomized, double-blind, parallel group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J. Allergy Clin. Immun. 119(1), S117 (2007
56. Casale TB, Busse WW, Kline JN et al. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J. Allergy Clin. Immunol. 117, 134-140 (2006
57. Srivastava KD, Kattan JD, Zou ZM et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J. Allergy Clin. Immunol. 115(1), 171-178 (2005
58. Srivastava KD, Zhang T, Qu C, Sampson HA, Li XM. Silencing peanut allergy: a Chinese herbal formula, FAHF-2, completely blocks peanut-induced anaphylaxis for up to 6 months following therapy in a murine model of peanut allergy. J. Allergy Clin. Immunol. 117(2), S328 (2006
59. Qu C, Srivastava K, Ko J, Zhang TF, Sampson HA, Li XM. Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferon-g. Clin. Exp. Allergy 37(6), 846-855 (2007
60. Ko J, Busse PJ, Shek L, Noone SA, Sampson HA, Li XM. Effect of Chinese herbal formulas on T cell responses in patients with peanut allergy or asthma J. Allergy Clin. Immunol. 115(2), S34 (2005
61. Liacouras CA, Spergel JM, Ruchelli E et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin. Gastroenterol. Hepatol. 3, 1198-1206 (2005
62. Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J. Allergy Clin. Immunol. 109, 363-368 (2002
63. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N. Engl. J. Med. 351, 940-941 (2004
64. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J. Clin. Invest. 107, 83-90 (2001
65. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic esophagitis is associated with a T(h)2-type allergic inflammatory response. J. Allergy Clin. Immunol. 108, 954-961 (2001
66. Stein ML, Collins MH, Villanueva JM et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J. Allergy Clin. Immunol. 118, 1312-1319 (2006
67. Bryan SA, O'Connor BJ, Matti S et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356, 2149-2153 (2000
68. Cortez-Perez NG, Ah-Leung S, Bermudez-Humaran LG et al. Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice. Clin. Vaccine Immunol. 14, 226-233 (2007
69. Ma Y, Hayglass KT, Becker AB et al. Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice. Allergy 62, 675-682 (2007 (Pubitemid 46763447)
70. Wang D, Kandimalla ER, Yu D, Agarwal S. Oral administration of secondgeneration immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity. Vaccine 23, 2614-2622 (2005
71. Zhu FG, Kanimalla ER, Yu D, Agarwal S. Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in mice. J. Allergy Clin. Immunol. 120, 631-637 (2007
72. Zhu D, Kepley CL, Zhang M, Zhang K, Saxon A. A novel human immunoglobulin Fcg-Fce bifunctional fusion protein inhibits FceRI-mediated degranulation. Nat. Med. 11, 446-449 (2005
73. Zhang K, Zhu D, Kepley C, Terada T, Saxon A. Chimeric human Fcg-allergen fusion proteins in the prevention of allergy. Immunol. Allergy Clin. N. Am. 27, 93-103 (2007